, a manufacturer of active ingredients, announced that the company's Bavla facility was successfully inspected by the US FDA in July, 2016, which was intimated to the stock exchanges on July 09, 2016. In this regard, the company has received the Establishment ... Myiris, 2 weeks ago
Dishman Pharma rises 4%, Bavla facility receives EIR from USFDA - Money Control, 2 weeks ago
Dishman Pharma receives EIR from USFDA for Bavla facility - Money Control, 2 weeks ago
More from: DNA, Business Line...and 1 other sources
on your WebpageAdd Widget >Get your members hooked!